학술논문
Safety, tolerability, and efficacy of PBT2 in Huntington's disease: A phase 2, randomised, double-blind, placebo-controlled trial
Document Type
Article
Author
Angus, D.; Herd, C.; Stone, C.; Stout, J.; Churchyard, A.; Murathodizic, M.; Wieler, M.; Reilmann, R.; Ritchie, C.W.; Dorsey, E.R.; Helles, K.; Kayson, E.; Oakes, D.; Rosas, H.D.; Vaughan, C.; Panegyres, P.K.; Ames, D.; Goh, A.; Agarwal, P.; Chua, P.; Germaine, D.; Lim, D.L.; Mack, H.; Loy, C.; Griffith, J.; Mitchell, P.; Corey-Bloom, J.; Gluhm, S.; Goldstein, J.; Levi, L.; Rosas, H.D.; Margolis, R.; Yoritomo, N.; Janicki, S.; Marder, K.; Clouse, R.; Singer, C.; Moore, H.; Padron, N.; Kostyk, S.; Daley, A.; Segro, V.; Kumar, R.; Anderson, K.; Drazinic, C.; Hennig, B.; Nance, M.; Molho, E.; Criswell, S.; LeDoux, M.S.; Guyot, S.; Iannaccone, A.; Jennings, B.; Leavitt, B.R.; Feigin, A.; Evans, S.; Wray, S.; Casaceli, C.; Orme, C.; Gao, S.; Watts, A.; Baker, K.; Labuschagne, I.; El-Dairi, M.; Fekrat, S.; Hersch, S.; Moscovitch-Lopatin, M.; Angus, D.; Herd, C.; Stone, C.; Ritchie, C.W.; Tanzi, R.; Targum, S.
Source
In: The Lancet Neurology . (The Lancet Neurology, 1 January 2015, 14(1):39-47)
Subject
Language
English
ISSN
14744465
14744422
14744422